TY - EJOU AU - Wu, Geting AU - Yan, Yuanliang AU - Zhou, Yangying AU - Duan, Yumei AU - Zeng, Shuangshuang AU - Wang, Xiang AU - Lin, Wei AU - Ou, Chunlin AU - Zhou, Jianhua AU - Xu, Zhijie TI - Sulforaphane: Expected to Become a Novel Antitumor Compound T2 - Oncology Research PY - 2020 VL - 28 IS - 4 SN - 1555-3906 AB - Natural products are becoming increasingly popular in a variety of traditional, complementary, and alternative systems due to their potency and slight side effects. Natural compounds have been shown to be effective against many human diseases, especially cancers. Sulforaphane (SFE) is a traditional Chinese herbal medicine. In recent years, an increasing number of studies have been conducted to evaluate the antitumor effect of SFE. The roles of SFE in cancers are mainly through the regulation of potential biomarkers to activate or inhibit related signaling pathways. SFE has exhibited promising inhibitory effects on breast cancer, lung cancer, liver cancer, and other malignant tumors. In this review, we summarized the reports on the activity and functional mechanisms of SFE in cancer treatment and explored the efficacy and toxicity of SFE. KW - Sulforaphane; Malignant tumor; Antitumor effects DO - 10.3727/096504020X15828892654385